Treatment with nipocalimab led to reduced lupus disease activity in phase 2 trial. (HealthDay News) — Nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a ...
Across the country, state leaders are racing to fast-track wind and solar projects before the expiration of federal tax credits to support clean energy. Colorado is directing state agencies to ...
The FDA's Fast Track designation helps to accelerate the development and review of products for serious and life-threatening conditions. The Food and Drug Administration (FDA) has granted Fast Track ...
CAMBRIDGE, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results